Evidence map›Paper›PMID 30155519›Full record

ArticleOpen medicine (Warsaw, Poland)2018

Genetic Risk in Insurance Field.

Paola Bin, Emanuele Capasso, Mariano Paternoster, Piergiorgio Fedeli, Fabio Policino, Claudia Casella, Adelaide Conti

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Regulation of Biobanks in Italy.Frontiers in pediatrics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Paola BinDepartment of Surgery, Radiology and Public Health, Public Health and Humanities Section, University of Brescia - Centre of Bioethics Research (with the contribution of IRCCS "S. Giovanni di Dio - Fatebenefratelli"), Italy. P.le Spedali Civili, 1, 25123, Brescia, Italy.
Emanuele CapassoDepartment of Advanced Biomedical Sciences, University of Naples Federico II. Via Sergio Pansini 5, 80131, Naples, Italy.
Mariano PaternosterDepartment of Advanced Biomedical Sciences, University of Naples Federico II. Via Sergio Pansini 5, 80131, Naples, Italy.
Piergiorgio FedeliJurisprudence School, University of Camerino, Via A. D'Accorso 16, 62032, Camerino (MC), Italy.
Fabio PolicinoDepartment of Advanced Biomedical Sciences, University of Naples Federico II. Via Sergio Pansini 5, 80131, Naples, Italy.
Claudia CasellaDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Section of Legal Medicine, Via Sergio Pansini 5, 80131, Naples, Italy.
Adelaide ContiDepartment of Surgery, Radiology and Public Health, Public Health and Humanities Section, University of Brescia - Centre of Bioethics Research (with the contribution of IRCCS "S. Giovanni di Dio - Fatebenefratelli"), Italy. P.le Spedali Civili, 1, 25123, Brescia, Italy.
University of Naples Federico II · ITUniversity of Brescia · ITUniversità di Camerino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk-delimiting tools available to insurance companies are therefore substantial and it is also possible to argue that a margin of uncertainty is a natural component of the insurance contract. Despite this, businesses look at the potential of predictive medicine, and in particular the growing understanding of genetic mechanisms that support many common diseases. In particular, the rapid development of genetics has led many insurance companies to glimpse in the predictive diagnosis of disease by genetic testing the possibility of extending the calculation of the individual risk of developing a particular disease to appropriate premiums or even denying insurance coverage.

Indexed as

GeneticsInsuranceRisk assessment

Identifiers

PMID30155519
PMCPMC6110137
OpenAlexW2889487684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.